Waters Corporation (NYSE:WAT) Director William J. Miller sold 3,500 shares of Waters stock in a transaction on Tuesday, December 5th. The shares were sold at an average price of $194.94, for a total transaction of $682,290.00. Following the sale, the director now directly owns 25,849 shares of the company’s stock, valued at approximately $5,039,004.06. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Shares of Waters Corporation (NYSE WAT) opened at $199.29 on Friday. The company has a quick ratio of 5.71, a current ratio of 6.16 and a debt-to-equity ratio of 0.66. Waters Corporation has a 52 week low of $133.71 and a 52 week high of $201.95. The stock has a market cap of $15,830.00, a price-to-earnings ratio of 27.11, a P/E/G ratio of 2.83 and a beta of 0.82.
Waters (NYSE:WAT) last announced its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 EPS for the quarter, topping the consensus estimate of $1.74 by $0.03. The firm had revenue of $565.58 million for the quarter, compared to the consensus estimate of $555.25 million. Waters had a net margin of 24.34% and a return on equity of 23.61%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.57 EPS. research analysts forecast that Waters Corporation will post 7.42 earnings per share for the current year.
A number of brokerages have issued reports on WAT. Morgan Stanley raised shares of Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 target price for the company in a research note on Monday, December 4th. Bank of America lifted their price objective on shares of Waters from $192.00 to $202.00 and gave the company a “neutral” rating in a research note on Friday, November 10th. Cowen reaffirmed a “hold” rating and issued a $190.00 price objective on shares of Waters in a research note on Friday, November 3rd. Zacks Investment Research lowered shares of Waters from a “buy” rating to a “hold” rating in a research note on Thursday, October 26th. Finally, Citigroup reaffirmed a “neutral” rating and issued a $180.00 price objective on shares of Waters in a research note on Wednesday, October 25th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $193.62.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. IFM Investors Pty Ltd bought a new position in Waters in the 3rd quarter worth $398,000. Bares Capital Management Inc. raised its holdings in Waters by 0.6% in the 3rd quarter. Bares Capital Management Inc. now owns 728,948 shares of the medical instruments supplier’s stock worth $130,861,000 after acquiring an additional 4,663 shares during the period. California Public Employees Retirement System raised its holdings in Waters by 6.6% in the 3rd quarter. California Public Employees Retirement System now owns 207,968 shares of the medical instruments supplier’s stock worth $37,334,000 after acquiring an additional 12,868 shares during the period. Janney Montgomery Scott LLC bought a new position in Waters in the 3rd quarter worth $459,000. Finally, Cubist Systematic Strategies LLC raised its holdings in Waters by 114.1% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 11,121 shares of the medical instruments supplier’s stock worth $1,996,000 after acquiring an additional 5,926 shares during the period. Hedge funds and other institutional investors own 92.29% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/09/waters-corporation-wat-director-sells-682290-00-in-stock.html.
Waters Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.